These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Embolia cutis medicamentosa after subcutaneous injection of pegylated interferon-alpha]. Sonntag M; Hodzic-Avdagic N; Bruch-Gerharz D; Neumann NJ Hautarzt; 2005 Oct; 56(10):968-9. PubMed ID: 16142495 [No Abstract] [Full Text] [Related]
6. IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report. Duncea I; Pepene CE J Gastrointestin Liver Dis; 2008 Dec; 17(4):453-6. PubMed ID: 19104709 [TBL] [Abstract][Full Text] [Related]
7. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain. Yachimski P; Chung RT AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393 [No Abstract] [Full Text] [Related]
8. [Interferon and cryoglobulinemia: how to inject without precipitation]. Touraud JP; Dalac S; Dutronc Y; Hillon P; Sgro C; Lambert D Gastroenterol Clin Biol; 2000; 24(8-9):854-5. PubMed ID: 11011266 [No Abstract] [Full Text] [Related]
9. High-dose interferon alfa-2A for the treatment of chronic hepatitis C. Watson AR; Bartlomé P Ann Pharmacother; 1994 Mar; 28(3):341-2. PubMed ID: 8193424 [No Abstract] [Full Text] [Related]
10. To C or not to C. Blanco A; Forbes R J Miss State Med Assoc; 2006 Aug; 47(8):227-9. PubMed ID: 17941238 [No Abstract] [Full Text] [Related]
11. Cutaneous ulcerations resulting from intramuscular injections of interferon alfa. Konohana A; Hasegawa Y; Kobayashi T J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):788-9. PubMed ID: 8912586 [No Abstract] [Full Text] [Related]
12. [Report of a case: hepatic failure after treatment with interferon]. Lindahl K; Weiland O; Schvarcz R Lakartidningen; 1993 Sep; 90(37):3075-6. PubMed ID: 8264269 [No Abstract] [Full Text] [Related]
13. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients. Bain VG; Kaita KD; Yoshida EM; Swain MG; Heathcote EJ; Neumann AU; Fiscella M; Yu R; Osborn BL; Cronin PW; Freimuth WW; McHutchison JG; Subramanian GM J Hepatol; 2006 Apr; 44(4):671-8. PubMed ID: 16487617 [TBL] [Abstract][Full Text] [Related]
14. [The peripheral polyneuropathy in patients with chronic HCV infection treated peginterferon alfa with ribavirin]. Lapiński TW; Nowacka B; Michalewicz M Pol Merkur Lekarski; 2005 Apr; 18(106):431-2. PubMed ID: 16161928 [TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance. Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996 [TBL] [Abstract][Full Text] [Related]
16. Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C. Christian MM; Diven DG; Sanchez RL; Soloway RD J Am Acad Dermatol; 1997 Jul; 37(1):118-20. PubMed ID: 9216535 [No Abstract] [Full Text] [Related]
19. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C. Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485 [No Abstract] [Full Text] [Related]
20. [Interferon-alpha and development of psoriatic arthropathy]. Piqueras Alcol B; de Diego Lorenzo A; Pérez Roldán F; Baños Díaz E; Clemente Ricote G An Med Interna; 1996 Oct; 13(10):512-3. PubMed ID: 9019204 [No Abstract] [Full Text] [Related] [Next] [New Search]